Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia.
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000502:physiology*; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism*; D004723:Endorphins / Q000378:metabolism*; D004745:Enkephalins / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D013134:Spiperone / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D004723:Endorphins; D004745:Enkephalins; D011759:Pyrrolidines; D013134:Spiperone; D014446:Tyrosine 3-Monooxygenase; D002795:Choline O-Acetyltransferase; D007608:Kainic Acid; D004298:Dopamine